Have your own idea? Try our Stock Screener
Spanish (IBEX) Biotech Industry Analysis
UpdatedApr 13, 2026
DataAggregated Company Financials
Companies4
- 7D-1.7%
- 3M-12.3%
- 1Y11.4%
- YTD-13.4%
Over the last 7 days, the Biotech industry has dropped 1.7%, driven by Grifols declining 2.9%. Over the past 12 months, the industry was up 16%. As for the next few years, earnings are expected to grow by 23% per annum.
Industry Valuation and Performance
Has the Spanish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 13 Apr 2026 | €7.4b | €7.8b | €472.3m | 18.3x | 15.7x | 1x |
| Wed, 11 Mar 2026 | €7.6b | €7.7b | €431.3m | 29.3x | 17.7x | 1x |
| Fri, 06 Feb 2026 | €8.2b | €7.7b | €401.9m | 29.2x | 20.3x | 1.1x |
| Sun, 04 Jan 2026 | €8.4b | €7.7b | €401.9m | 29.6x | 20.8x | 1.1x |
| Tue, 02 Dec 2025 | €7.9b | €7.7b | €401.9m | 28.1x | 19.7x | 1x |
| Thu, 30 Oct 2025 | €8.5b | €7.6b | €332.3m | 28.1x | 25.5x | 1.1x |
| Sat, 27 Sep 2025 | €9.0b | €7.6b | €332.3m | 31.6x | 27.2x | 1.2x |
| Mon, 25 Aug 2025 | €9.2b | €7.6b | €332.3m | 31.5x | 27.8x | 1.2x |
| Wed, 23 Jul 2025 | €8.8b | €7.6b | €208.3m | 55.1x | 42.1x | 1.2x |
| Fri, 20 Jun 2025 | €7.9b | €7.6b | €208.2m | 53.8x | 38x | 1x |
| Sun, 18 May 2025 | €7.2b | €7.6b | €208.0m | 50.4x | 34.6x | 1x |
| Tue, 15 Apr 2025 | €6.6b | €7.4b | €176.3m | 43.4x | 37.4x | 0.9x |
| Thu, 13 Mar 2025 | €7.5b | €7.4b | €176.3m | 50.5x | 42.8x | 1x |
| Sat, 08 Feb 2025 | €7.0b | €7.2b | €154.6m | 1285.9x | 45x | 1x |
| Mon, 06 Jan 2025 | €7.4b | €7.2b | €154.6m | 1179x | 47.8x | 1x |
| Wed, 04 Dec 2024 | €6.9b | €7.2b | €154.7m | 1169.2x | 44.4x | 1x |
| Fri, 01 Nov 2024 | €7.9b | €7.0b | €159.1m | -352.3x | 49.4x | 1.1x |
| Sun, 29 Sep 2024 | €7.4b | €7.0b | €161.7m | 27.3x | 45.7x | 1.1x |
| Tue, 27 Aug 2024 | €6.8b | €7.0b | €165.5m | 25.9x | 40.9x | 1x |
| Thu, 25 Jul 2024 | €6.6b | €6.8b | €189.7m | 33x | 34.8x | 1x |
| Sat, 22 Jun 2024 | €6.3b | €6.8b | €189.6m | 32.8x | 33x | 0.9x |
| Mon, 20 May 2024 | €6.7b | €6.8b | €189.7m | 35.5x | 35.4x | 1x |
| Wed, 17 Apr 2024 | €5.8b | €6.8b | €58.5m | 98.2x | 99.2x | 0.9x |
| Fri, 15 Mar 2024 | €5.0b | €6.8b | €55.1m | 267.7x | 91.3x | 0.7x |
| Sun, 11 Feb 2024 | €7.0b | €6.7b | €31.4m | 171.5x | 224x | 1x |
| Tue, 09 Jan 2024 | €9.5b | €6.7b | €31.5m | 233.9x | 302.6x | 1.4x |
| Thu, 07 Dec 2023 | €9.2b | €6.7b | €31.4m | 227.4x | 292.3x | 1.4x |
| Sat, 04 Nov 2023 | €7.9b | €6.7b | €16.4m | 492x | 479.9x | 1.2x |
| Mon, 02 Oct 2023 | €8.1b | €6.7b | €23.8m | 510x | 341.4x | 1.2x |
| Wed, 30 Aug 2023 | €8.5b | €6.7b | €23.8m | 530.1x | 355.2x | 1.3x |
| Fri, 28 Jul 2023 | €8.6b | €6.6b | €70.1m | 106.5x | 123.3x | 1.3x |
| Sun, 25 Jun 2023 | €7.6b | €6.6b | €69.4m | 92.9x | 110.1x | 1.2x |
| Tue, 23 May 2023 | €7.9b | €6.6b | €69.3m | 96.3x | 113.4x | 1.2x |
| Thu, 20 Apr 2023 | €6.6b | €6.3b | €251.5m | 22.8x | 26.2x | 1x |
Price to Earnings Ratio
26.2x
Current Industry PE
- Investors are pessimistic on the Spanish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 15.7x which is lower than its 3-year average PE of 97.2x.
- The 3-year average PS ratio of 1.1x is higher than the industry's current PS ratio of 0.96x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have grown 23% per year over the last three years.
- Revenues for these companies have grown 7.3% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Spanish Healthcare industry?
| ES Market | 3.46% | |
| Healthcare | 0.93% | |
| Biotech | -1.74% | |
| Biotech | -1.74% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PHM Pharma Mar | €92.90 | 2.1% +€33.0m | 21.4% | PE21.5x | |
| ORY Oryzon Genomics | €2.84 | 1.8% +€3.9m | 2.2% | PS20.1x |